(Q40240733)

English

Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus

scientific article published on 22 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

0 references

author name string

Robben JH

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sze M

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Knoers NV

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Deen PM

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

22 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

292

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

F253-60

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

V2 receptor antagonists in cystic kidney diseases: an exciting step towards a practical treatment

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Pharmacological chaperone action on G-protein-coupled receptors.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Unexpected effects of epitope and chimeric tags on gonadotropin-releasing hormone receptors: implications for understanding the molecular etiology of hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Molecular and cellular defects in nephrogenic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): A potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Obesity-associated mutations in the human melanocortin-4 receptor gene

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C-terminus

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Rescue of vasopressin V2 receptor mutants by chemical chaperones: specificity and mechanism

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Influence of molecular and chemical chaperones on protein folding

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2006

21 January 2018

Identifiers

10.1152/AJPRENAL.00247.2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

release_vste2tapljazlfdepkm6shyfja

1 reference

https://api.fatcat.wiki/v0/release/vste2tapljazlfdepkm6shyfja

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40240733&oldid=1889778607"